PANCREATIC CANCER METASTATIC
Clinical trials for PANCREATIC CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC CANCER METASTATIC trials appear
Sign up with your email to follow new studies for PANCREATIC CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Virus-Immunotherapy cocktail takes on tough GI cancers
Disease control OngoingThis early-stage trial is testing a combination of pelareorep (a reovirus) and atezolizumab (an immunotherapy) along with standard chemotherapies in people with advanced anal or pancreatic cancers. The study aims to find safe doses, look for biomarkers that predict response, and …
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Oncolytics Biotech • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug combo shows promise in tough pancreatic cancer
Disease control OngoingThis study tests a new drug called narmafotinib, taken as a daily pill, together with a standard chemotherapy regimen (mFOLFIRINOX) in people whose pancreatic cancer has spread. The trial has two parts: first, finding a safe dose, then comparing two doses in 20 people each. The g…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Amplia Therapeutics Limited • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can digestive enzymes help pancreatic cancer patients keep weight on?
Disease control OngoingThis study tests whether taking pancreatic enzymes (Pertzye) with meals can help people with metastatic pancreatic cancer maintain their body weight during chemotherapy. The trial includes 17 participants who are starting a standard chemo regimen called FOLFIRINOX. Researchers wi…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Can a common diabetes drug help pancreatic cancer patients control blood sugar?
Disease control OngoingThis phase 2 trial is testing the safety and effectiveness of glipizide, a standard diabetes drug, for lowering blood sugar in people with pancreatic cancer. The study includes 29 participants with active pancreatic cancer and high blood sugar. Researchers will measure blood suga…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC